Clinical Trials Directory

Trials / Unknown

UnknownNCT01340339

Reverse Phototherapy With Super Light-emitting Diode(Super-LED) for Hyperbilirubinemia in Term and Late Preterm Infants

Efficacy of Reverse Phototherapy With Super Light-emitting Diode(Super-led) in Term and Late Preterm Infants:Randomized and Controlled Clinical Trial

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
144 (estimated)
Sponsor
Professor Fernando Figueira Integral Medicine Institute · Academic / Other
Sex
All
Age
35 Weeks – 41 Weeks
Healthy volunteers
Not accepted

Summary

The aim of this study is to compare the efficacy of super-LED reverse phototherapy with the fluorescent reverse phototherapy in term and late preterm newborns.

Detailed description

This is a randomized controlled clinical trial with hospitalized infants in the Professor Fernando Figueira Medicine Institute(IMIP), who require phototherapy as an indication of the medical team. Following the sample calculation, 144 patients will be randomized according to gestational age (350/7-376/7 or 380/7-416/7 weeks) to receive super-LED reverse phototherapy or fluorescent reverse phototherapy with spectral irradiance of 8-12 microwatts/cm2/nm.The bilirubin will be determined by micromethod with bilirubinometer, after blood collection in heparinized capillary until bilirubin reaches level that indicates suspension of therapy.

Conditions

Interventions

TypeNameDescription
DEVICEPhototherapyFluorescent reverse phototherapy (7 white lights 5cm below the base of acrylic cot), with spectral irradiance of 8-12microwatts/cm2/nm; daily; until bilirubin reaches level that indicates suspension of therapy
DEVICEPhototherapysuper LED reverse phototherapy (17 bulbs arranged in 42 x 31 cm in blue base acrylic cot), with spectral irradiance of 8-12microwatts/cm2/nm; daily; until bilirubin reaches level that indicates suspension of therapy

Timeline

Start date
2010-10-01
Primary completion
2011-10-01
Completion
2012-01-01
First posted
2011-04-22
Last updated
2011-04-22

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01340339. Inclusion in this directory is not an endorsement.